With the likes of Pfizer and Moderna leading in the race to a coronavirus vaccine, AstraZeneca shares have dropped by 3% following the company’s announcement that its vaccine candidate has proven to be 70% effective. This figure is significantly lower than that of Pfizer and Moderna.
In its phase 3...
After a 17% surge on Tuesday that resulted in a two-month high, hydrogen vehicle manufacturer Nikola suffered a 15% decrease in stock prices as markets came to a close. The Phoenix-based firm enjoyed a significant rise over the past few weeks in line with the electric vehicle market.
Nikola’s late...
While U.S. crude supplies have experienced a steady decline in recent times, oil has managed to retain its eight-month market highs. While an Energy Information Administration report showed a 754,000 decline in crude barrels last week, oil futures rose by 1.8% on the New York Stock Exchange.
These enduring highs...
The majority of Middle Eastern stock markets enjoyed a modest rise as last week’s trading came to a close. This increase was largely fueled by rising crude oil prices as well as other gains in emerging markets.
Indexes across gulf nations Bahrain and Saudi Arabia, in addition to Abu Dhabi...
With online spending on Black Friday rising by 21.6% to $9 billion this year, Cyber Monday has been projected to be the biggest online shopping day to date. With sales estimates being projected to be anywhere between $10.8 billion and $12.7 billion, the NYSE has seen some major movements...
With supply chain issues disrupting the manufacturing process, pharmaceutical company Pfizer has announced that the due date for the delivery of its COVID-19 vaccines has been slightly delayed.
In an interview with The Wall Street Journal, a spokesperson for Pfizer stated that it took longer than expected to scale the...
Pharmaceutical company AstraZeneca Plc has decided to make a move to purchase rare-disease specialist Alexion Pharmaceuticals Inc. for a hefty price tag of $39 billion. According to AstraZeneca, this move will account for the majority of the company’s growth, particularly following its low-return attempt at developing a COVID-19 vaccine...
With the first rollout of the coronavirus vaccine and the approval of federal pandemic relief edging closer, a wave of optimism sharply drove up the value of U.S. stock futures on Monday. Across the ocean, Europe’s markets enjoyed a rally of their own, fueled by the hopes of an...
With Monday’s COVID-19 vaccine rollout leading to the rise of riskier stocks, gold prices have suffered a minor decline, with spot gold falling by 0.4% to $1,831.75 per ounce. U.S. gold futures declined by 0.4% as well to a price of $1,836.80.
While news that a $908 billion U.S. COVID-19...
Moderna analyst Matthew Harrison predicts that his company’s stock prices will be heavily influenced by the FDA panel meeting that will take place on Thursday regarding the distribution of the biotech firm’s vaccine candidate.
Described by Harrison as “the most innovative vaccine developer” that is capable of outperforming the majority...